Epredia, Aiforia to distribute AI-based pathology software

Create PDF

“With their global presence in the pathology market and our expertise in delivering AI-based solutions for pathologists, Epredia is the ideal commercial partner to help us broaden the international reach of Aiforia’s powerful AI software to pathologists working in clinical diagnostics and preclinical drug development,” Jukka Tapaninen, CEO of Aiforia, said in a press statement. “Our mission is to become a global leader in AI-assisted image analysis to improve the efficiencies of healthcare systems and enable better patient outcomes.”

According to Aiforia, more than 3,000 pathologists and scientists in more than 50 countries use its software.